Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Immunology
|
June 1, 1993
Variations in serum sCD23 in conditions with either enhanced humoral or cell-mediated immunity
A S Bansal, W Ollier, M N Marsh, et al.
International Journal of Cancer
|
March 30, 1999
TGF-beta1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis
C Li, P B Wilson, E Levine, et al.
The Journal of Biological Chemistry
|
October 15, 1988
Agonist-induced down-regulation of the angiotensin II receptor in primary cultures of rat hepatocytes
B Bouscarel, P B Wilson, P F Blackmore, et al.
Lancet (London, England)
|
July 24, 1993
Cellular and humoral immunity in patients with insulin-dependent diabetes
A S Bansal, P B Wilson, R S Pumphrey, et al.
International Journal of Cancer
|
February 7, 2001
Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer
C Li, B Guo, P B Wilson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 1, 1991
Deficiencies in anti-acetylcholine receptor antibody measurement in myasthenia gravis
C E Clarke, D I Shepherd, G M Yuill, et al.
Journal of Immunological Methods
|
November 18, 1998
Immunodetection and characterisation of soluble CD105-TGFbeta complexes
C G Li, P B Wilson, C Bernabeu, et al.
Clinical and Experimental Immunology
|
September 1, 1992
Soluble CD23 levels are elevated in the serum of patients with primary Sjögren's syndrome and systemic lupus erythematosus
A Bansal, T Roberts, E M Hay, et al.
Atherosclerosis
|
September 21, 2000
The significance of CD105, TGFbeta and CD105/TGFbeta complexes in coronary artery disease
C G Li, H Bethell, P B Wilson, et al.
Immunology
|
December 1, 1993
Serum measurements of soluble CD23 in HIV infection
A S Bansal, R S Pumphrey, B K Mandal, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Immunology
|
June 1, 1993
Variations in serum sCD23 in conditions with either enhanced humoral or cell-mediated immunity
A S Bansal, W Ollier, M N Marsh, et al.
International Journal of Cancer
|
March 30, 1999
TGF-beta1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis
C Li, P B Wilson, E Levine, et al.
The Journal of Biological Chemistry
|
October 15, 1988
Agonist-induced down-regulation of the angiotensin II receptor in primary cultures of rat hepatocytes
B Bouscarel, P B Wilson, P F Blackmore, et al.
Lancet (London, England)
|
July 24, 1993
Cellular and humoral immunity in patients with insulin-dependent diabetes
A S Bansal, P B Wilson, R S Pumphrey, et al.
International Journal of Cancer
|
February 7, 2001
Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer
C Li, B Guo, P B Wilson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 1, 1991
Deficiencies in anti-acetylcholine receptor antibody measurement in myasthenia gravis
C E Clarke, D I Shepherd, G M Yuill, et al.
Journal of Immunological Methods
|
November 18, 1998
Immunodetection and characterisation of soluble CD105-TGFbeta complexes
C G Li, P B Wilson, C Bernabeu, et al.
Clinical and Experimental Immunology
|
September 1, 1992
Soluble CD23 levels are elevated in the serum of patients with primary Sjögren's syndrome and systemic lupus erythematosus
A Bansal, T Roberts, E M Hay, et al.
Atherosclerosis
|
September 21, 2000
The significance of CD105, TGFbeta and CD105/TGFbeta complexes in coronary artery disease
C G Li, H Bethell, P B Wilson, et al.
Immunology
|
December 1, 1993
Serum measurements of soluble CD23 in HIV infection
A S Bansal, R S Pumphrey, B K Mandal, et al.
Page
of 4